Adolescent Biological Aging Linked to Obesity, Inflammation, and Future Heart Risk
Background
Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality globally. While traditional risk factors like obesity and inflammation are well-established, the early life origins of these risks, particularly during adolescence, are less understood. This study investigates whether accelerated biological aging, measured epigenetically, in adolescents predicts later-life cardiovascular risk factors.
Study Design
Results
The study found a significant association between epigenetic age acceleration (EAA) in adolescence and adverse health outcomes later in life. Adolescents with higher EAA showed a 25% greater likelihood of having elevated BMI in middle age. Furthermore, EAA was positively correlated with markers of inflammation, with a 1.8-fold increase in C-reactive protein levels for every 1-year increase in EAA. > The most striking finding was that each 1-year increase in adolescent EAA was associated with a 15% higher cardiovascular disease (CVD) risk score in middle age (p<0.001), independent of chronological age. This suggests that biological aging outpaces chronological aging in some adolescents, predisposing them to greater metabolic and cardiovascular burdens. The associations remained significant even after adjusting for traditional risk factors, indicating EAA as an independent predictor.
Why It Matters
This research highlights epigenetic age acceleration as a crucial, early-life biomarker for future cardiovascular disease risk. Identifying adolescents with accelerated biological aging could enable targeted early interventions to mitigate the progression of chronic diseases. Future steps could involve developing screening tools for EAA in youth and exploring lifestyle or pharmacological interventions that could slow down epigenetic aging. This could pave the way for novel preventative strategies.